279 related articles for article (PubMed ID: 8104853)
1. [Indications spectrum for beta-1-selective adrenergic receptor blockers].
Dotzer F; Gromer H
Fortschr Med; 1993 Aug; 111(24):382-4. PubMed ID: 8104853
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide mechanisms of nebivolol.
Maffei A; Lembo G
Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):317-27. PubMed ID: 19443516
[TBL] [Abstract][Full Text] [Related]
3. The role of the new beta-blockers in treating cardiovascular disease.
Weber MA
Am J Hypertens; 2005 Dec; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
[TBL] [Abstract][Full Text] [Related]
4. [Beta receptor blockers. Their role and therapeutic importance].
Regenthal R; Voigt H; Preiss R
Z Gesamte Inn Med; 1991; 46(1-2):1-5. PubMed ID: 1674828
[TBL] [Abstract][Full Text] [Related]
5. [Present trends and controversies in the use of beta-blockers in cardiovascular diseases].
Spoladore R; Fragasso G; Montanaro C; Maranta F; Torlasco C; Gerosa S; Margonato A
Recenti Prog Med; 2010 Nov; 101(11):429-41. PubMed ID: 21197763
[TBL] [Abstract][Full Text] [Related]
6. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
Leenen FH; Davies RA; Fourney A
Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
8. Clinical manifestations of hyperthyroidism after treatment with selective beta 1 adrenoceptor blocking agents.
Shikara MM; Polena S; Solinas A; Sanghvi K; Gintautas J
Proc West Pharmacol Soc; 2003; 46():125-6. PubMed ID: 14699906
[No Abstract] [Full Text] [Related]
9. Are we misunderstanding beta-blockers.
Cruickshank JM
Int J Cardiol; 2007 Aug; 120(1):10-27. PubMed ID: 17433471
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
11. Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Dahlöf B; Devereux RB; Kjeldsen SE; Lyle PA; Zhang Z; Edelman JM
Blood Press; 2007; 16(1):6-12. PubMed ID: 17453746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of talinolol and atenolol effects on blood pressure in relation to lipid and glucose metabolic parameters. Results from the TALIP study.
Sourgens H; Schmidt J; Derendorf H
Int J Clin Pharmacol Ther; 2003 Jan; 41(1):22-9. PubMed ID: 12564742
[TBL] [Abstract][Full Text] [Related]
13. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
Raos V; Bergovec M
Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
[TBL] [Abstract][Full Text] [Related]
14. [Beta-adrenergic receptor blockers in clinical practice].
Czuriga I; Edes I
Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
[TBL] [Abstract][Full Text] [Related]
15. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
[TBL] [Abstract][Full Text] [Related]
16. [Role of beta-blockers in the treatment of arterial hypertension].
Goose P; Dallocchio M
Ann Cardiol Angeiol (Paris); 1989 Feb; 38(2):115-9. PubMed ID: 2565100
[TBL] [Abstract][Full Text] [Related]
17. [Atenolol in treatment of patients with airway obstruction].
Chazan R
Pol Merkur Lekarski; 1996 Dec; 1(6):428-30. PubMed ID: 9273241
[TBL] [Abstract][Full Text] [Related]
18. Do we need a new classification of beta-blockers?
Kendall MJ
J Hum Hypertens; 1990 Jun; 4 Suppl 2():27-9. PubMed ID: 1973460
[TBL] [Abstract][Full Text] [Related]
19. Optimizing treatment of diabetes and cardiovascular disease with combined alpha,beta-blockade.
Bell DS
Curr Med Res Opin; 2005 Aug; 21(8):1191-200. PubMed ID: 16083528
[TBL] [Abstract][Full Text] [Related]
20. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
Mehvar R; Brocks DR
J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
